Literature DB >> 9520569

Knowledge of disease and dietary compliance in patients with end-stage renal disease.

R C Katz1, J Ashmore, E Barboa, K Trueblood, V McLaughlin, L Mathews.   

Abstract

Noncompliance is a common problem in patients with end-stage renal disease. In this study, we assessed the relationship between knowledge of disease and dietary compliance in a cohort of 56 dialysis patients. Based on a health belief model of adherence, we predicted that dialysis patients who knew more about kidney disease and its treatment would be more complaint than those who knew less about these matters. We also examined the relationship between dietary compliance and patients' emotional well-being. We used a composite measure of compliance consisting of serum K, P, and interdialytic weight gain. A 30-item "Kidney Disease Questionnaire" was used to assess patients' knowledge of their illness. Contrary to prediction, compliers did not score higher on the knowledge questionnaire; in fact, the observed correlation of .32 was in the opposite direction. In the same vein, we found no relationship between compliance and emotional well-being. These results, although somewhat surprising, add to a growing body of research which indicates that medical compliance involves more than educating patients about the mechanisms and treatment of their illness.

Entities:  

Mesh:

Year:  1998        PMID: 9520569     DOI: 10.2466/pr0.1998.82.1.331

Source DB:  PubMed          Journal:  Psychol Rep        ISSN: 0033-2941


  2 in total

Review 1.  Monitoring drug adherence.

Authors:  Sarah R Lieber; Jacqueline Helcer; Eyal Shemesh
Journal:  Transplant Rev (Orlando)       Date:  2015-04       Impact factor: 3.943

2.  Remote Health Monitoring for Older Adults and Those with Heart Failure: Adherence and System Usability.

Authors:  Jarrett Evans; Amy Papadopoulos; Christine Tsien Silvers; Neil Charness; Walter R Boot; Loretta Schlachta-Fairchild; Cindy Crump; Michele Martinez; Carrie Beth Ent
Journal:  Telemed J E Health       Date:  2015-11-05       Impact factor: 3.536

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.